Study Links Accelerated Biological Aging to Higher Dementia Risk in Women
Aging is a natural process, yet individuals experience it at varying rates. Biological age refers to the condition of one’s cells, distinct from chronological age, which is simply the number of years since birth. A recent study published in Scientific Reports has examined the long-term risks associated with accelerated biological aging, particularly its relationship with dementia and cardiovascular disease. The study involved over 3,000 participants and aimed to uncover gender differences in health outcomes related to biological aging.
The researchers utilized data from the Framingham Offspring Study, carefully excluding participants lacking clinical biomarker data necessary to estimate biological age. They focused on three primary outcomes: cardiovascular disease, dementia, and all-cause mortality. Key measurements included total blood cholesterol, blood sugar levels, and Mini-Mental State Exam scores, with various biomarkers employed based on the specific health outcome being analyzed. Covariates such as diabetes, medication use for blood pressure, and smoking status were also considered.
Participants were categorized into three groups based on their biological age: accelerated, decelerated, or concordant, with most falling into the concordant category, indicating their biological age matched their chronological age. Notably, those with accelerated biological age exhibited a higher risk for cardiovascular disease, with men showing a 1.6-fold increase and women a 1.8-fold increase compared to those with decelerated biological age. Additionally, both genders with accelerated biological aging faced a twofold increase in mortality risk.
However, the study revealed a significant gender disparity regarding dementia risk. While accelerated biological aging did not statistically increase dementia risk in men, women with accelerated biological aging were found to be at a higher risk. Sensitivity analyses confirmed that even women with a concordant biological age faced increased dementia risk compared to their decelerated counterparts.
It is crucial to note that this study is observational, meaning it cannot definitively establish causation. The authors acknowledged limitations in their methodology, particularly the lack of a standardized approach to calculating biological age, which could lead to variations in research findings. Furthermore, the study's participant demographic, predominantly white individuals of European descent, may limit the generalizability of the results.
Experts not involved in the study, such as Dr. Salim Hayek from The University of Texas Medical Branch, emphasized the need for caution in interpreting the findings. He pointed out that while biological age can indicate risk, it does not provide additional predictive power beyond established risk factors like chronological age and lifestyle choices. Future research should delve into factors contributing to accelerated biological aging and its implications for health management.
The study authors suggest that understanding biological aging may help identify individuals at risk for adverse health outcomes not captured by traditional biomarkers. They advocate for establishing standards in measuring biological age to enhance its clinical relevance. Dr. Cheng-Han Chen, another expert, noted the potential for a standardized definition of biological age to aid in identifying individuals at greater risk for age-related conditions, although he cautioned that more research is necessary before biological age can be routinely used in clinical practice.




